At 17.8% CAGR, the Middle East & Africa Organoids Market is Projected to be Worth US$ 289.76 Million by 2031, Says Business Market Insights

According to Business Market Insights research, the Middle East & Africa organoids market was valued at US$ 77.94 million in 2023 and is expected to reach US$ 289.76 million by 2031, registering a CAGR of 17.8% from 2023 to 2031. Combination of organoids and organ-on-a-chip and increasing demand for tumor modeling and biobanking are among the critical factors attributed to the Middle East & Africa organoids market expansion.

Technological advancements enabling the combination of organoids with organ-on-a-chip facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening. Organoids and organ-on-a-chip, which serve as evolving pathological and human physiological in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. Organoid-on-a-chip, the incorporation of multiple organoids on a chip, exhibits the benefits of both organoid and organ-on-a-chip as well as provides a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.

Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, and more. Organoid-on-a-chip is an emerging segment with much scope for improvement. Thus, with cooperative efforts from interdisciplinary researchers to reach the full utility of organoids in human biomedical studies, the combination of organoids and organ-on-a-chip is emerging as a significant trend in the organoids market.

On the contrary, dearth of skilled professionals hampers the growth of Middle East & Africa organoids market.

Based on type, the Middle East & Africa organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held 23.0% share of the Middle East & Africa organoids market in 2023, amassing US$ 17.94 million. It is projected to garner US$ 65.47 million by 2031 to expand at 17.6% CAGR during 2023–2031.

Based on application, the Middle East & Africa organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held 29.8% share of the Middle East & Africa organoids market in 2023, amassing US$ 23.26 million. It is projected to garner US$ 90.48 million by 2031 to expand at 18.5% CAGR during 2023–2031.

Based on source, the Middle East & Africa organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held 72.3% share of the Middle East & Africa organoids market in 2023, amassing US$ 56.35 million. It is projected to garner US$ 216.11 million by 2031 to expand at 18.3% CAGR during 2023–2031.

Based on offering, the Middle East & Africa organoids market is segmented into instruments, consumables, and services. The consumables segment held 56.8% share of the Middle East & Africa organoids market in 2023, amassing US$ 44.31 million. It is projected to garner US$ 164.50 million by 2031 to expand at 17.8% CAGR during 2023–2031. The instruments segment is further subsegmented into devices and equipment. The consumables segment is further subsegmented into sensors and others.

Based on method, the Middle East & Africa organoids market is segmented into micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others. The hanging drop segment held 42.0% share of the Middle East & Africa organoids market in 2023, amassing US$ 32.73 million. It is projected to garner US$ 118.12 million by 2031 to expand at 17.4% CAGR during 2023–2031.

Based on country, the Middle East & Africa organoids market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 33.9% share of Middle East & Africa organoids market in 2023, amassing US$ 26.43 million. It is projected to garner US$ 96.64 million by 2031 to expand at 17.6% CAGR during 2023–2031.

Key players operating in the organoids market are STEMCELL Technologies Inc; Molecular Devices, LLC.; Hubrecht Organoid Technology; Definigen; Organoid Therapeutics; Thermo Fisher Scientific Inc; Corning Inc; Merck KGaA; InSphero; ACRO Biosystems; Bio-Techne Corp; SUN bioscience SA; ORGANOID SCIENCES Co., Ltd.; Crown Bioscience Inc; Sartorius AG; 3D Biotek LLC; Prellis Biologics Inc.; 3Dnamics Inc.; and Cellesce Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com